Simulated Consultation Feedback

Critical Misses

• Neurological symptoms relevant to B12 deficiency were not assessed before deciding treatment, despite the patient later mentioning balance worries.
• Management was not safely tailored to possible neurological involvement because urgency and regimen decisions were made without that assessment.
• Injection counselling was incomplete, with no material discussion of side effects, allergy risk, or monitoring plan.

What Went Well

• Clarified the reason for the blood tests and revisited the history of tiredness and sore tongue.
• Asked about some alternative causes or contributors including diet, alcohol, mood, and medication history.
• Recognised that low haemoglobin and low B12 explained the anaemia and glossitis.
• Noted that thyroid function was normal and addressed the patient’s prior thought that this might be thyroid-related.
• Correctly told the patient she would need treatment and that this would be by injections.
• Recognised that long-term treatment would be needed rather than a simple thyroid dose change.
• Tried to adapt logistics by offering specific appointment times to fit around her caring duties.
• Arranged follow-up in one month.
• Acknowledged that caring for Ted was difficult and asked about support.
• Adapted the practical plan around the patient’s need for dependable appointment times.
• Used generally understandable language when explaining anaemia and low B12.
• Maintained a polite and respectful manner throughout.

Important Omissions

• Did not actively assess for neurological symptoms of B12 deficiency such as paraesthesia, numbness, gait disturbance, falls, or bladder/bowel symptoms before management.
• Did not explore severity of anaemia symptoms beyond mild breathlessness on stairs, such as broader functional impact or other relevant red flags in a targeted way.
• Did not meaningfully explain the significance of the positive intrinsic factor antibody beyond naming pernicious anaemia.
• Did not build and verbalise a fuller diagnostic formulation including the cause of the B12 deficiency and why this affects treatment choice.
• Did not tailor urgency or regimen to neurological status because this was not assessed.
• Gave incomplete and partly inaccurate injection schedule information for this case.
• Did not explain why pernicious anaemia means lifelong replacement and that oral shop-bought remedies would not be appropriate treatment.
• Did not provide material counselling about injection side effects or allergic reactions.
• Did not discuss monitoring plan such as follow-up blood tests and symptom review.
• Safety-netting was limited and not sufficiently specific overall for this case’s uncertainty and risk.
• Did not address broader care needs such as support for her caring role despite this clearly affecting treatment attendance.
• Did not fully respond to the patient’s initial anxiety about whether the blood result was serious.
• ICE was asked but only partly used to shape explanation and planning.
• Missed an important cue when the patient said she worried about her balance, without exploring it.
• Repeated holding phrases and delayed explanation of results despite the patient repeatedly asking to understand them.
• Did not check understanding in a meaningful way after giving a lifelong diagnosis and injection plan.

Patient-centredness

You did ask about worries and expectations, and you picked up the practical impact of her caring role. The best patient-centred part of the consultation was negotiating dependable appointment times around Ted. However, ICE was only partly used: Margaret’s repeated wish to know whether this was serious, get quick clarity, and manage treatment around caring duties should have shaped the consultation earlier and more clearly. Important emotional and clinical cues, especially her anxiety and later mention of balance, needed fuller exploration.

Safety-netting

You did give some safety-netting about weakness, bladder or bowel problems, and walking or balance issues needing urgent attention, which was helpful. However, it came late, was not well linked to the diagnosis, and was not specific enough overall for the level of uncertainty in this case. A stronger close would have explained exactly what should trigger urgent contact, what improvement to expect over time, and what to do if symptoms worsened or new neurological features appeared.

Clarity and Jargon

Most of your explanation was understandable, particularly linking low haemoglobin to anaemia and low B12. 'Pernicious anaemia' was named, but the meaning of the intrinsic factor result and why this makes treatment lifelong were not clearly explained. There were also a few unclear or garbled phrases in the transcript, but the main issue was less about jargon and more about incomplete explanation.

Management Feedback

You correctly moved toward B12 injection treatment rather than changing thyroid medication, and you made a useful practical adjustment for attendance. The main problem was that management rested on an incomplete assessment. In a case like this, you need to establish whether there are neurological symptoms before deciding pace and regimen, then explain why lifelong injections are needed, what the early treatment schedule is, what side effects or risks to watch for, what monitoring will happen, and when improvement is expected.

Three Priority Improvements

• Actively screen for neurological features of B12 deficiency before finalising diagnosis and treatment plan, especially if there are any cues about balance, numbness, tingling, or walking.
• When giving a results-based diagnosis, explain the cause and consequence clearly: what the antibody means, why this is pernicious anaemia, and why lifelong injections are needed.
• Strengthen your closing management summary with specific counselling, follow-up, and actionable safety-netting, rather than a brief generic warning list.